Kirk Heyne

879 citations

19 papers · 537 indexed · h-index 8

Impact in

Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis

Papers in

Hepatology 6
- Hepatocellular Carcinoma Treatment and Prognosis 6
- Liver Disease and Transplantation 2
Otorhinolaryngology 2

Co-authors: J. Jack Lee Scott M. Lippman Waun Ki Hong Ashish Saharia David W. Victor Garam Choi Dong M. Shin Helmuth Goepfert
Journals: Cancers (4 papers)Journal of Clinical Oncology (4 papers)JNCI Journal of the National Cancer Institute (1 paper)Blood (1 paper)The Lancet. Gastroenterology & hepatology (1 paper)
Partner nations: United States Egypt Jordan

In The Last Decade

Kirk Heyne

17 papers receiving 530 citations

Peers

Countries citing papers authored by Kirk Heyne

Since Specialization

Citations

This map shows the geographic impact of Kirk Heyne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirk Heyne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirk Heyne more than expected).

Fields of papers citing papers by Kirk Heyne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirk Heyne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirk Heyne. The network helps show where Kirk Heyne may publish in the future.

Co-authors

The 25 scholars most cited alongside Kirk Heyne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kirk Heyne Line = papers co-authored together Kirk Heyne links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Transplant Oncology: An Emerging Discipline of Cancer Treatment Cancers ·Maen Abdelrahim, Abdullah Esmail, Ala Abudayyeh, Naoka Murakami, David W. Victor, Sudha Kodali, Yee Lee Cheah, Caroline J. Simon, Mazen Noureddin, Ashton A. Connor, Ashish Saharia, Linda W. Moore, Kirk Heyne, Ahmed O. Kaseb, A. Osama Gaber, Rafik M. Ghobrial	2023	7
2	Infections and their impact on patients on pembrolizumab-based therapies for head and neck cancer. Journal of Clinical Oncology ·Yuqi Zhang, Jiaqiong Xu, Ibrahim N. Muhsen, Ethan Burns, 安西利恵, Valentine L. MIKHEICHEVA, Rujukan Upp, Kai Sun, Xiaoying Ma, Abdullah Esmail, H Lars, André Machado-Alves, Zimu Gong, Petras Girdžius, Kirk Heyne, 江君理, Jun Zhang, Maen Abdelrahim	2022	1
3	Outcomes of patients with advanced urothelial cancer who develop infection while on treatment with pembrolizumab. Journal of Clinical Oncology ·H Lars, Siti Fatimatuzzahra Binti Roseli, Ethan Burns, Ibrahim N. Muhsen, 安西利恵, Valentine L. MIKHEICHEVA, Rujukan Upp, Catty Castillo-Caicedo, Yuqi Zhang, Xiaoying Ma, Abdullah Esmail, Raphael Sermet, Zimu Gong, Petras Girdžius, Kirk Heyne, 江君理, Jun Zhang, Eleni Efstathiou, Eric Bernicker, Maen Abdelrahim	2022	1
4	P-161 Trial in progress: Neoadjuvant combination therapy of lenvatinib plus transcatheter arterial chemoembolization (TACE) for transplant-eligible patients with large hepatocellular carcinoma Annals of Oncology ·Maen Abdelrahim, Abdullah Esmail, Ashish Saharia, Sudha Kodali, David W. Victor, Kirk Heyne, R. Mark Ghobrial	2022	3
5	Combination of transarterial chemoembolization (TACE) and tyrosine kinase inhibitors (TKIs) compared to TACE alone as bridging therapy transplant recipients with hepatocellular carcinoma: An update. Journal of Clinical Oncology ·Abdullah Esmail, David W. Victor, Sudha Kodali, Edward A. Graviss, Duc T. Nguyen, Linda W. Moore, Ashish Saharia, Robert McMillan, Joy Nolte Fong, Ahmed Uosef, 悌夫河村, Kirk Heyne, Rafik M. Ghobrial, Maen Abdelrahim	2022	2
6	Transarterial Chemoembolization (TACE) Plus Sorafenib Compared to TACE Alone in Transplant Recipients with Hepatocellular Carcinoma: An Institution Experience Cancers ·Maen Abdelrahim, David W. Victor, Abdullah Esmail, Sudha Kodali, Edward A. Graviss, Duc T. Nguyen, Linda W. Moore, Ashish Saharia, Robert McMillan, Joy Nolte Fong, Ahmed Uosef, 悌夫河村, Kirk Heyne, Rafik M. Ghobrial	2022	31
7	Impact of Infections in Patients Receiving Pembrolizumab-Based Therapies for Non-Small Cell Lung Cancer Cancers ·Ethan Burns, Petras Girdžius, H Lars, Siti Fatimatuzzahra Binti Roseli, Yuqi Zhang, Xiaoying Ma, Ibrahim N. Muhsen, Rujukan Upp, Abdullah Esmail, 安西利恵, Valentine L. MIKHEICHEVA, Catty Castillo-Caicedo, Raphael Sermet, Zimu Gong, Kirk Heyne, 江君理, Jun Zhang, Eric Bernicker, Maen Abdelrahim	2022	6
8	Transplant Oncology: An Evolving Field in Cancer Care Cancers ·Maen Abdelrahim, Abdullah Esmail, Ala Abudayyeh, Naoka Murakami, Ashish Saharia, Robert McMillan, David W. Victor, Sudha Kodali, Akshay Shetty, Joy Nolte Fong, Linda W. Moore, Kirk Heyne, A. Osama Gaber, Rafik M. Ghobrial	2021	40
9	Primary and Secondary Central Nervous System Lymphoma: Outcomes from Houston Methodist Cancer Center Blood ·Артур Андреевич Ледовских, Ethan Burns, Ibrahim N. Muhsen, آویشن اربابی, Raphael Sermet, John Rogers, Matthew D. Cykowski, Joe Ensor, Kirk Heyne, Jorge Darcourt, Jasleen K. Randhawa, Hamid Raheem, Sai Ravi Pingali	2020	0
10	Viable Hemostasis Obtained With Prothrombin Complex Concentrate in Patients Who Refuse Standard Allogeneic Blood Transfusion and Undergo Complex Cardiac Surgery: A Case Series A&A Practice ·Oon Wee Chin, Синіговець Ігор, Ana Jozinović, Eric Salazar, Kirk Heyne, Jill P. Williamson, Kira Meyer, Joshua T. Swan	2020	1
11	The Liver That Cured Christmas: Case Report of Orthotopic Liver Transplant in a Patient with Hemophilia B SHILAP Revista de lepidopterología ·Ana Jozinović, Sun Hui, Constance M. Mobley, Kirk Heyne	2020	1
12	Is Surgery-first Still a Reasonable Option in the Era of Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer? American Journal of Clinical Oncology ·Ashish Saharia, Domingo Alberto Román-Montes De, Vidya M.J, P. Naveena Sri, Constance M. Mobley, Rafik M. Ghobrial, Maen Abdelrahim, Kirk Heyne	2019	2
13	Aortic Valve Replacement in Severe Factor V Deficiency and Inhibitor: Diagnostic and Management Challenges Cureus ·Ryan Goode, Eric Salazar, Kirk Heyne, Joseph Varón	2019	0
14	Pazopanib-Induced Pneumonitis: A Case Report Haruhiko Tsuzuki, Claudia Karen Espinosa Arce, Salim Surani, Joseph Varón, Kirk Heyne	2019	1
15	Outcomes of Liver Transplantation for Hepatocellular Carcinoma Beyond the University of California San Francisco Criteria: A Single-center Experience Transplantation ·David W. Victor, Howard Monsour, Maha Boktour, Keri E. Lunsford, Julius Balogh, Edward A. Graviss, Duc T. Nguyen, Robert McFadden, Mukul Divatia, Kirk Heyne, Victor Ankoma‐Sey, Ilídio João Moutinho Sanito, Joseph Galati, Andrea Duchini, Ashish Saharia, Constance M. Mobley, A. Osama Gaber, R. Mark Ghobrial	2019	20
16	Promising new treatments for pancreatic cancer in the era of targeted and immune therapies. PubMed ·P. Naveena Sri, Ashish Saharia, Domingo Alberto Román-Montes De, Vidya M.J, M. Petit, Maen Abdelrahim, Kirk Heyne	2019	20
17	Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series The Lancet. Gastroenterology & hepatology ·Keri E. Lunsford, Milind Javle, Kirk Heyne, Rachna T. Shroff, Reham Abdel‐Wahab, Nakul Gupta, Constance M. Mobley, Ashish Saharia, David W. Victor, Duc T. Nguyen, Edward A. Graviss, Ahmed O. Kaseb, Robert McFadden, Thomas A. Aloia, Claudius Conrad, Li X, Howard Monsour, A. Osama Gaber, Jean‐Nicolas Vauthey, R. Mark Ghobrial	2018	175
18	p53 Expression: Predicting Recurrence and Second Primary Tumors in Head and Neck Squamous Cell Carcinoma JNCI Journal of the National Cancer Institute ·Dong M. Shin, Jack Lee, Scott M. Lippman, J. Jack Lee, Z. Nora Tu, Garam Choi, Kirk Heyne, 泰雄樋口, Jae Y. Ro, Helmuth Goepfert, Waun Ki Hong, Walter N. Hittelman	1996	153
19	The incidence of second primary tumors in long-term survivors of small-cell lung cancer. Journal of Clinical Oncology ·Kirk Heyne, Scott M. Lippman, J. Jack Lee, Thanh Hung Ngo, Waun Ki Hong	1992	73

About Kirk Heyne

Kirk Heyne is a scholar working on Hepatology, Otorhinolaryngology, Oncology, Hematology and Critical Care and Intensive Care Medicine, having authored 19 papers that have together received 537 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Liver Disease and Transplantation (2 papers) and Viral-associated cancers and disorders (2 papers). The work is most often cited by research in Otorhinolaryngology (82 citations), Hepatology (114 citations), Oncology (311 citations), Surgery (278 citations) and Transplantation (13 citations). Kirk Heyne has collaborated with scholars based in United States, Egypt and Jordan. Frequent co-authors include J. Jack Lee, Scott M. Lippman, Waun Ki Hong, Ashish Saharia, David W. Victor, Garam Choi, Dong M. Shin, Helmuth Goepfert, Walter N. Hittelman and Jae Y. Ro. Their work appears in journals such as Cancers, Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute, Blood and The Lancet. Gastroenterology & hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact